Father of Lights
Wednesday, December 29, 2021
Tuesday, December 28, 2021
Monday, December 27, 2021
Sunday, December 26, 2021
O Irão faz exercÃcios militares no Golfo Pérsico
Irão diz que exercÃcio militar no Golfo é “aviso” a Israel
Negociações para acordo sobre o nuclear iraniano recomeçam na segunda-feira em Viena num clima de pessimismo.O Irão afirmou que os exercÃcios militares que levou a cabo esta semana no Golfo Pérsico tiveram como objectivo “fazer um aviso” a Israel, quando aumenta a preocupação que Israel possa planear atacar alvos nucleares no Irão – isto quando as negociações que decorrem em Viena para um acordo nuclear recomeçam já na segunda-feira e diplomatas dizem que a janela para um acordo começa a apertar-se.
As manobras dos Guardas da Revolução incluÃram o disparo de mÃsseis balÃsticos e de cruzeiro. “Estes exercÃcios tiveram uma mensagem clara: um aviso sério, real, à s ameaças do regime sionista [as autoridades iranianas nunca se referem a Israel pelo nome, por não o reconhecerem como um Estado], para ter atenção aos seus erros”, declarou o chefe dos Guardas da Revolução, Hossein Salami, à televisão estatal. “Vamos cortar-lhes as mãos se derem um passo em falso. A distância entre operações concretas e exercÃcios militares é apenas uma mudança no ângulo do lançamento dos mÃsseis”, acrescentou.
Israel tem ameaçado levar a cabo ataques militares para destruir o programa nuclear iraniano se isso for necessário mas responsáveis da defesa, citados quer pelo jornal norte-americano New York Times quer pelo israelita Haaretz, dizem que o paÃs não tem – pelo menos ainda não tem nem terá em breve – a capacidade para levar a cabo um ataque em larga escala. Dentro das possibilidades reais estaria apenas alguns ataques a alguns dos locais.
Até agora, Israel tem levado a cabo acções de pequena escala, desde actos de sabotagem a assassÃnios de pessoas ligadas ao programa nuclear – sem as admitir ou reivindicar.
A discussão de um ataque tem sido vista como fazendo parte da campanha de pressão de Israel sobre os poderes discutindo o acordo nuclear com o Irão em Viena. O Estado hebraico tem alertado para duas possibilidades: uma, de que o Irão esteja a tentar “ganhar tempo” e arrastar as negociações o mais possÃvel até conseguir obter urânio enriquecido suficiente para uma bomba, e outra, para que os poderes assinem um “mau acordo”, que não impeça o Irão de desenvolver armas nucleares.
O chefe dos negociadores europeus, Enrique Mora, falou de uma “pausa decepcionante”, e que nesta próxima ronda, a oitava, seria “discutido como avançar”.
Esta semana, o conselheiro de segurança nacional dos EUA Jake Sullivan esteve em Israel, onde foi questionado sobre que margem temporal existe para que se chegue a um acordo – que é patrocinado pelos EUA (que não participa, no entanto, nas conversações de forma directa). “Não estamos a marcar uma data no calendário em público, mas posso dizer que atrás de portas fechadas estamos a falar de horizontes temporais, e não são longos” – avançando que são na ordem das “semanas”.
Uma declaração do ministro dos Negócios Estrangeiros de Israel Yair Lapid, de que Israel não teria problemas com um acordo que “limitasse de modo permanente a sua capacidade para obter uma arma nuclear” pode, especulava o New York Times, reflectir, em parte, a conclusão de que um acordo é muito improvável – ou Lapid não concordaria com um acordo com um paÃs que provoca tanta desconfiança em Israel. Ainda há cerca de um mês o primeiro-ministro, Naftali Bennett, afirmou que Israel não ficaria vinculado pelo acordo e não abdicaria da sua “liberdade de acção”.
O Irão prometeu entretanto que mesmo sem acordo não vai enriquecer urânio a mais de 60%, disse o chefe da Organização de Energia Atómica Mohammad Eslami a uma televisão estatal russa. O acordo de 2015 apenas permitia um enriquecimento a 3,67%, suficiente para a maioria das utilizações civis e limitava a sua quantidade, para não poder continuar a ser enriquecido e chegar aos 90% necessários para uma bomba.
Depois de o então Presidente norte-americano Donald Trump retirar os EUA do acordo, em 2018, o Irão começou a enriquecer a 20% em alguns locais e, este ano (na sequência de uma explosão numa central atómica atribuÃda a Israel), a 60%. Um enriquecimento a mais de 20% aumenta o potencial para ser usado para fins militares, porque, explica a BBC, o esforço necessário para os 20% é a maior parte (90%) do esforço total para o fazer chegar aos 90% necessários para poder ser usado em armas. Chegando, por exemplo, a 170 quilos de urânio enriquecido a 20%, é possÃvel produzir 25 quilos de urânio enriquecido a 90% em menos de dois meses.
Vários paÃses estimam que a quantidade que o regime iraniano dispõe será suficiente para dentro de algumas semanas ter o suficiente para o enriquecer rapidamente a 90% e conseguir fazer uma bomba, diz o diário israelita Haaretz.
maria.joao.guimaraes@publico.pt
Dennis Edwards: Fique de olho no Irã, na Turquia e na Rússia. Eles parecem ser as três potências militares que invadirão Israel nos últimos dias. Tal diz a profecia de Ezequiel nos capÃtulos 38 e 39 do Antigo Testamento. O retorno de Cristo para interromper a guerra e impor a paz na terra por 1.000 anos ocorre nessa época. Mas primeiro teremos o governo mundial, o lÃder mundial do anticristo e a diabólica Marca da Besta. Não deixe o governo marcar você com sua marca, seja um implante de microchip ou vacina, ou uma tatuagem invisÃvel. Pode estar mais perto do que você pensa.
Saturday, December 25, 2021
Ivermectin Trial Supply Issues?
Screenshot of countries where ivermectin is used for COVID-19. (ivmstatus.com/screenshot via The Epoch Times)
No Supply Issues With Ivermectin: Pharmaceutical Supplying PRINCIPLE Oxford Trial
The New Jersey pharmaceutical company supplying ivermectin to a UK trial that was paused for a short period of time, says there are no supply issues with its pills.
Ivermectin is being investigated as part of the government-backed Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses (PRINCIPLE) in the United Kingdom as a possible home treatment for COVID-19.... The trial was put on hold due to “temporary supply issues” as reported by Medpage Today on Dec. 14.
Details were not provided on the cause of the supply issues. The trial’s joint chief investigator, professor Chris Butler, and the trial’s press team declined to comment and respond to a query asking when the supply issue is expected to be resolved.
The Epoch Times also reached out to Torbay and South Devon NHS Foundation Trust in England—one of two organizations responsible for QP (quality person) release, importing, and, labeling of ivermectin in the trial—but did not receive a reply.
Daniel Worley Jr., Vice President of Business Development and Associate General Counsel of Edinbridge Pharmaceuticals, the manufacturer supplying the medicine, told The Epoch Times in an email that the company “is not experiencing any supply issues related to its ivermectin tablets (3mg) product.”
The company’s ivermectin tablets were added to the World Health Organization’s (WHO) Prequalified Medicines List last year in September, which ensures that a medicine meets “acceptable standards of quality, safety, and efficacy” for international procurement agencies to purchase and distribute in “resource-limited countries.” The list is part of the United Nation’s Prequalification of Medicines Programme and is run by the WHO.
The halt on the trial has since been lifted as of Friday. However, PRINCIPLE says it is now pausing “for registrations over the Festive Break” and will “reopen for registrations on January 4th,” according to the trial’s website.
Doctors Question Lack of Ivermectin Supply
When PRINCIPLE announced its ivermectin trial in June 2021, Butler, the co-chief investigator, said the drug was safe and readily available, suggesting that there was an appropriate supply of the drug.
“Ivermectin is readily available globally, has been in wide use for many other infectious conditions, so it’s a well-known medicine with a good safety profile, and because of the early promising results in some studies it is already being widely used to treat COVID-19 in several countries,” Butler said in a news release.
Several doctors questioned the sudden pause on the PRINCIPLE trial as a result of the ivermectin supply.
Dr. Tess Lawrie, director of the Evidence-based Medicine Consultancy, said the supply issue cited was “plainly ridiculous.” The WHO is one of Lawrie’s company’s clientele.
“To cite supply issues is plainly ridiculous,” Lawrie told The Epoch Times via email. “We are talking about a most abundant off-patent medicine that is produced in many countries around the world. There are many European manufacturers too, including Huvepharma in Bulgaria.”
Chief of the Division of Pulmonary and Critical Care Medicine at the Eastern Virginia Medical School Dr. Paul Marik said the reason given by PRINCIPLE was “nonsense.”
“It’s clear this is an ominous plot. A supply issue with IVERMECTIN; you must be kidding,” Marik told The Epoch Times in an email. “After 3.7 BILLION doses have been dispensed in the last 2 decades; we have a supply issue; what nonsense.”
Marik is also the co-founder of a medical organization called the Front Line COVID-19 Critical Care (FLCCC) Alliance that has developed several COVID-19 treatment protocols using ivermectin as “a core medication in the prevention and treatment” along with other medicines that are federally approved, “inexpensive, readily available, and have been used for decades with well-established safety profiles.”
Dr. Robert Malone, the inventor of the messenger RNA vaccine technology, says that it is unlikely there is a shortage of ivermectin, alleging the Oxford University team was either lying or incompetent.
“The first thing you do before you launch the study is you lock down your trial supply so that one completely fails the sniff test,” Malone said on Fox’s “The Ingraham Angle” show. [Watch this]
“Either they’re grossly incompetent at the University of Oxford or lying. It’s one or the other because [the] worldwide supply of ivermectin is enormous, and there’s no way that a competent clinical research team would not have locked down their trial supply.”
The Oxford University trial team did not reply to The Epoch Times’ request for comment.
The U.S. Food and Drug Administration (FDA), the WHO, and the European Medicines Agency advises against the use of the anti-parasitic drug for COVID-19, claiming that more data are needed on its effectiveness and safety. Still, some countries like Mexico and Uttar Pradesh, India, widely made ivermectin available as part of their treatment protocol to treat COVID-19.
Proponents of the drug say that the oral FDA-approved ivermectin formulation for humans, which comes in tablet forms, has a high safety profile. About 4.4 billion doses of the medicine (renamed Mectizan) have been administered in 49 countries to treat river blindness and lymphatic filariasis since 1987. In 2020 alone, “a total of 417 million Mectizan treatments were approved,” according to the Mectizan Donation Program (pdf).
According to the National Institutes of Health (NIH), ivermectin is “generally well tolerated” with minimal side effects that include dizziness, nausea, or diarrhea. The NIH neither recommends for nor against the use of ivermectin for COVID-19.
In addition, world-known French toxicologist, Prof. Jacques Descotes, in his comprehensive assessment of the safety profile of ivermectin based on an analysis of more than 350 articles, concluded that “the safety profile of ivermectin has so far been excellent in the majority of treated human patients so that ivermectin human toxicity cannot be claimed to be a serious cause for concern.”
He also wrote in his analysis (pdf) that, “The present extensive review of adverse events reportedly associated with ivermectin treatment for [the] therapeutic or prophylactic purpose did not reveal any significant cause for concern. … In fact, adverse events were mainly mild to moderate and infrequent.”
Meiling Lee is a health reporter for The Epoch Times.
USA Swimming Offical Quits Over Transgender Male Swimmer
USA Swimming Official Quits In Protest Of Lia Thomas: ‘Everything Fair About Swimming Is Being Destroyed’
By Ashe Schow• Dec 24, 2021 DailyWire.com•
Penn Athletics
An official with USA Swimming has resigned in protest over University of Pennsylvania swimmer Lia Thomas, who competed as a male for three years before identifying and competing as a woman. So far, Thomas has shatter women’s swimming records by massive amounts while many continue to claim transgender women have no biological advantage over women.
The Washington Times reported that Cynthia Millen “has officiated at USA Swimming events for 30 years, but she hung up her whistle last week in protest over Penn transgender swimmer Lia Thomas, and she hopes others will follow her lead.”
Millen told the outlet she notified USA Swimming of her resignation on December 17 in a letter, saying she made the decision while packing for the U.S. Paralympics Swimming National Championships in Greensboro, North Carolina.
“I can’t do this, I can’t support this,” she said.
“I told my fellow officials that I can no longer participate in a sport which allows biological men to compete against women. Everything fair about swimming is being destroyed,” she wrote in the letter, which she provided to the Times.
As The Daily Wire previously reported, Thomas’ times while swimming for the men’s team “would break seven-time gold medal Olympic champion Katie Ledecky’s college times.”
Millen told the Times that if she had to officiate a swim meet where Thomas competed, she would have to rule the senior ineligible to compete as a woman.
“If Lia came on my deck as a referee, I would pull the coach aside and say, ‘Lia can swim, but Lia can swim exhibition or a time trial. Lia cannot compete against those women because that’s not fair,’” Millen told the outlet.
Millen also called on other volunteer officials to protest any meets that include transgender women competing against women.
“This is not right because by doing this, we’re supporting this,” Millen told the Times. “There are no swim meets if there are no officials.”
Multiple Penn students have spoken out anonymously about the inherent unfairness in allowing Thomas to compete against women. Students told The Daily Wire of their frustrations surrounding Thomas’ spot on the women’s team.
“Their idea of ‘acceptance’ is to not give you a platform — by shaming or forcing you out if you have views that are too far from their own,” one student said. “For a university where we are all supposed to bring ideas and differing viewpoints to grow, the pressure to be silent rings loud and has catastrophic implications.”
“You don’t need a life science degree to know that testosterone gives a massive advantage for physical strength. Not to mention increased red blood cell counts that provide greater oxygenation during long distance exercises, lower natural body fat percentages, and so on,” another student said. “Biological men are physically advantaged over women by nature.”
Neither the NCAA nor USA Swimming have commented publicly on the Thomas situation.
The Daily Wire is one of America’s fastest-growing conservative media companies and counter-cultural outlets for news, opinion, and entertainment. Get inside access to The Daily Wire by becoming a member.
By Ashe Schow• Dec 24, 2021 DailyWire.com•
Penn AthleticsAn official with USA Swimming has resigned in protest over University of Pennsylvania swimmer Lia Thomas, who competed as a male for three years before identifying and competing as a woman. So far, Thomas has shatter women’s swimming records by massive amounts while many continue to claim transgender women have no biological advantage over women.
The Washington Times reported that Cynthia Millen “has officiated at USA Swimming events for 30 years, but she hung up her whistle last week in protest over Penn transgender swimmer Lia Thomas, and she hopes others will follow her lead.”
Millen told the outlet she notified USA Swimming of her resignation on December 17 in a letter, saying she made the decision while packing for the U.S. Paralympics Swimming National Championships in Greensboro, North Carolina.
“I can’t do this, I can’t support this,” she said.
“I told my fellow officials that I can no longer participate in a sport which allows biological men to compete against women. Everything fair about swimming is being destroyed,” she wrote in the letter, which she provided to the Times.
As The Daily Wire previously reported, Thomas’ times while swimming for the men’s team “would break seven-time gold medal Olympic champion Katie Ledecky’s college times.”
Millen told the Times that if she had to officiate a swim meet where Thomas competed, she would have to rule the senior ineligible to compete as a woman.
“If Lia came on my deck as a referee, I would pull the coach aside and say, ‘Lia can swim, but Lia can swim exhibition or a time trial. Lia cannot compete against those women because that’s not fair,’” Millen told the outlet.
Millen also called on other volunteer officials to protest any meets that include transgender women competing against women.
“This is not right because by doing this, we’re supporting this,” Millen told the Times. “There are no swim meets if there are no officials.”
Multiple Penn students have spoken out anonymously about the inherent unfairness in allowing Thomas to compete against women. Students told The Daily Wire of their frustrations surrounding Thomas’ spot on the women’s team.
“Their idea of ‘acceptance’ is to not give you a platform — by shaming or forcing you out if you have views that are too far from their own,” one student said. “For a university where we are all supposed to bring ideas and differing viewpoints to grow, the pressure to be silent rings loud and has catastrophic implications.”
“You don’t need a life science degree to know that testosterone gives a massive advantage for physical strength. Not to mention increased red blood cell counts that provide greater oxygenation during long distance exercises, lower natural body fat percentages, and so on,” another student said. “Biological men are physically advantaged over women by nature.”
Neither the NCAA nor USA Swimming have commented publicly on the Thomas situation.
The Daily Wire is one of America’s fastest-growing conservative media companies and counter-cultural outlets for news, opinion, and entertainment. Get inside access to The Daily Wire by becoming a member.
